COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,684 Articles (22,913 medRxiv, 8,771 bioRxiv)

Most recent first Previous |  Page 875: Articles 8741-8750  | Next

Second round of the interlaboratory comparison (ILC) exercise of SARS-CoV-2 molecular detection assays being used by 45 veterinary diagnostic laboratories in the US
Deng, K., Uhlig, S., Goodman, L. B., Ip, H. S., Killian, M. L., Nemser, S. M., Ulaszek, J., Kiener, S., Kmet, M., Frost, K., Hettwer, K., Colson, B., Nichani, K., Schlierf, A., Tkachenko, A., Mlalazi-Oyinloye, M., Scott, A., Reddy, R., Tyson, G. H.
10.1101/2022.04.08.22273621 — Posted: 2022-04-10
SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in the northeast of Brazil
Freire Neto, F. P., Teixeira, D., Cunha, D. C. S., Morais, I. C., Tavares, C. P. M., Gurgel, G. P., Nascimento, S. D., Santos, D. C., Sales, A. O., Jeronimo, S. M. B.
10.1101/2022.04.08.22272726 — Posted: 2022-04-10
Self-Reported Mask Use in SARS-CoV-2 Vaccinated and Unvaccinated Populations
Calamari, L. E., Tjaden, A. H., Edelstein, S. L., Weintraub, W. S., Santos, R., Gibbs, M. A., Ward, J., Santacatterina, M., Bertoni, A. G., Ward, L. M., Saydah, S., Plumb, I. D., Runyon, M. S., The COVID-19 Community Research Partnership Study Group
10.1101/2022.04.06.22273448 — Posted: 2022-04-10
Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 - February 2022
Kim, S., Chung, J., Talbot, K., Grijalva, C. G., Wernli, K., Kiniry, E., Martin, E. T., Monto, A., Belongia, E., McLean, H. Q., Gaglani, M., Mamawala, M., Nowalk, M. P., Moehling Geffel, K., Tartof, S., Florea, A., Lee, J. S., Tenforde, M. W., Patel, M., Flannery, B.
10.1101/2022.04.06.22273535 — Posted: 2022-04-10
Implications of red state/blue state differences in COVID-19 death rates
Adams, M.
10.1101/2022.04.08.22273628 — Posted: 2022-04-10
Longitudinal associations between physical activity and other health behaviours during the COVID-19 pandemic: A fixed effects analysis
Mitchell, J. J., Bu, F., Fancourt, D., Steptoe, A., Bone, J. K.
10.1101/2022.04.07.22273555 — Posted: 2022-04-10
Time series cross-correlation between home range and number of infected people during the medium term of COVID-19 Pandemic in a suburban city
KATO, H., Takizawa, A.
10.1101/2022.04.07.22273581 — Posted: 2022-04-10
Effectiveness of convalescent plasma therapy in COVID-19 patients with haematological malignancies
Shibeeb, S., Ajaj, I., Al-Jighefee, H., Abdallah, A.
10.1101/2022.04.06.22273542 — Posted: 2022-04-10
Protocol for mixed-method study by LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the NHS (LOCOMOTION)
Sivan, M., Greenhalgh, T., Darbyshire, J. L., Mir, G., O'Connor, R. J., Dawes, H., Greenwood, D., O'Connor, D., Horton, M., Petrou, S., de Lusignan, S., Curcin, V., Mayer, E., Casson, A., Milne, R., Rayner, C., Smith, N., Parkin, A., Preston, N. J., Delaney, B. C., LOCOMOTION CONSORTIUM
10.1101/2022.04.09.22273655 — Posted: 2022-04-10
THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions
Bertsimas, D., Li, M. L., Soni, S.
10.1101/2022.04.09.22273656 — Posted: 2022-04-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).